163 related articles for article (PubMed ID: 1752785)
1. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
Ebina T; Murata K
Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
Ebina T; Kohya H; Ishikawa K
Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.
Ebina T; Murata K
Jpn J Cancer Res; 1990 Dec; 81(12):1307-13. PubMed ID: 2126000
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
Ebina T; Kohya H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
Ebina T; Kohya H
Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of interleukin-1 beta in the double grafted tumor system.
Ebina T; Ishikawa K
Jpn J Cancer Res; 1989 Jun; 80(6):570-6. PubMed ID: 2503477
[TBL] [Abstract][Full Text] [Related]
10. [Differences of antitumor effect of various BRMs by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.
Ebina T; Fujimiya Y
Biotherapy; 1998; 11(4):259-65. PubMed ID: 9950102
[TBL] [Abstract][Full Text] [Related]
12. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
13. Timed daily administration of prolactin and corticosteroid hormone reduces murine tumor growth and enhances immune reactivity.
Keisari Y; Cincotta E; Meier AH; Cincotta AH
Chronobiol Int; 1999 May; 16(3):315-33. PubMed ID: 10373101
[TBL] [Abstract][Full Text] [Related]
14. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
Kohya H; Ebina T; Yamaguchi T; Ishida N
Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
[TBL] [Abstract][Full Text] [Related]
15. [Regional adoptive immunotherapy using activated lymphocytes].
Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
[TBL] [Abstract][Full Text] [Related]
16. Changes in cellular composition induced by neocarzinostatin pretreatment in Meth A-bearing mice and the responsible antitumor effector cells.
Masuda E; Shishido T; Fujimoto R; Maeda H
Immunopharmacology; 1997 Aug; 37(1):105-16. PubMed ID: 9285249
[TBL] [Abstract][Full Text] [Related]
17. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
Ozawa H; Iwaguchi T; Kataoka T
J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
[TBL] [Abstract][Full Text] [Related]
18. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
